9th AIDS Seminar in KUMAMOTO
   
   9th AIDS Seminar in KUMAMOTO Program
   
    ■ 18 September
    ■ 19 September
    ■ Poster Session

■ Poster Session
P01 Terumasa Ikeda [Kumamoto Univ.]
The anti-retroviral potency of APOBEC1 cytidine deaminase from small animal species

P02 Eri Takeda [Kinki Univ.]
An APOBEC3 isoform expressed in C57BL/6 mice exhibits a physiological restricting activity against Friend retrovirus infection and pathogenesis.

P03 Taisuke Izumi [Kyoto Univ.]
HIV-1 Vif Causes G2 Cell Cycle Arrest via the p53 Pathway

P04 Mikako Fujita [Kumamoto Univ.]
Functional analysis of HIV-2 Vpx protein

P05 Noriyuki Okudaira [IMCJ]
Retrotransposition of LINE-1 by HIV-1 Vpr.

P06 Yuzuru Minemoto [IMCJ]
An association between HIV-1 Vpr and Snf2h, a chromatin remodeling factor, facilitates viral integration into pericentromeric heterochromatin

P07
Seiji Yamamoto [Kyoto Univ.]
Functional association of HIV-1 and MoMLV integrase with HECT-domain ubiquitin ligase Huwe1

P08 Masateru Hiyoshi [Kumamoto Univ.]
Dys-regulated activation of a Src tyrosine kinase Hck at the Golgi apparatus by Nef impairs protein Glycosylation and trafficking

P09 Kenji Ohba [NIID]
Follicular dendritic cells activate HIV-1 replication through a juxtacrine mechanism mediated by P-selectin glycoprotein ligand-1

P10 Shoukichi Takahama [Ehime Univ./
NIID]
"Atypical protein kinase C (aPKC), a cell polarity regulating kinase,
phosphorylates HIV-1 Gag"


P11 Ayumu Kuroishi [Osaka Univ.]
Engineering of HIV-1 able to replicate in simian cells

P12 Kenta Matsuda [Kyoto Univ.]
Construction and in vivo analysis of R5 tropic SHIV

P13 Yu-ya Mitsuki [NIID]
"Selective transmission of R5 HIV-1 over X4 HIV-1at the dendritic cell?T cell infectious synapse
is determined by the T cell activation state"


P14
Keisuke Yusa [Kumamoto Univ.]
The effect of virion incorporated CCR5 on R5 HIV-1 infectivity

P15 Yosuke Maeda [Kumamoto Univ.]
Analyses of post-entry restriction of HIV-1 infection in human T cell lines

P16 Tetsuya Kimura [Kumamoto Univ.]
Role of N-linked glycosylation in N-terminus region of V2 loop of HIV-1 gp120 for resistance to neutralization by anti-V3 antibody.

P17
Chisato Narahara [Kumamoto Univ.]
Different mutation in HIV-1 gp120 V3-tip region for escape from a potent neutralizing anti-V3 monoclonal antibody during in vitro selection with low or high concentration of the Mab

P18 Makiko Hatada [Kumamoto Univ.]
The impact of an N-linked glycosylation site insertion in HIV-1 gp120 V2 region to escape from a potent neutralization anti-V3 monoclonal antibody

P19
Jagdagsuren Davaalkham [IMCJ]
High Risk Status of HIV-1 Infection in the Very Low Epidemic Country, Mongolia, 2007

P20
Tamayo Watanabe [IMCJ]
Patterns of AIDS-related complications at the International Medical Center of Japan (IMCJ) in HAART era

P21
Tsunefusa Hayashida [IMCJ]
Analysis of new patients who visited ACC in 2003, 2007, and 2008 using BED assay

P22
Tomomi Towata [Kumamoto Univ.]
Inhibitory Effect of Drug-Free Hybrid Liposomes on Primary Effusion Lymphoma

P23 Shinichiro Hattori [Kumamoto Univ.]
Protection of CD4+ Cells against HIV-1 Infection by 4’-Ethynyl-2-Fluoro-2’- Deoxyadenosine in hu-PBMC NOD/SCID/Jak-3-KO AIDS mice

P24 Manabu Aoki [Kumamoto Univ.]
Role of Gag Mutations in HIV in Its Replication Fitness and Acquisition of Resistance to Protease Inhibitors

P25 Masayuki Amano [Kumamoto Univ.]
Spontaneous Degradation of Gag Proteins in Multi-drug-resistant HIV-1 Variants Containing Insertions in Gag Proteins

P26 Takayuki Hamasaki [Kagoshima Univ.]
In silico screening of anti-HIV-1 compounds targeting cyclin T1

P27 Naoki Kobayashi [Kumamoto Univ.]
The immature differentiation of human T cells in humanized NOD/SCID/Jak3-/- mice

P28 Takuya Yamamoto [NIID]
SIV-specific functional T-cell induction after passive neutralizing antibody immunization postinfection

P29
Tetsuya Kuwano [Univ. of Tokyo]
Influence of MHC-I polymorphisms on the efficacy of a T cell-based vaccine in a macaque AIDS model

P30
Yoshinori Fukazawa [Kyoto Univ.]
Live attenuated AIDS vaccine conferred a strong protection against highly pathogenic SHIV challenge.

P31
Katsuhisa Inaba [Kyoto Univ.]
CD4+ cell reduction and enteropathy in small intestine can be occurred irrespective of viral load in simian/human immunodeficiency virus infection.

P32 Kei Matsuki [Nagasaki Univ.]
Fine mapping of epitope regions recognized by HIV-1-Specific Cytotoxic T Lymphocytes

P33 Philip Mwimanzi [Kumamoto Univ].
The effects of CTL-escape conferring mutations on Nef's pathogenic functions in primary macrophages.

P34
Chihiro Motozono [Kumamoto Univ.]
The decay of peptide-MHC complex influences antiviral activity of HIV-specific CTLs

P35 Nan Zheng [Kumamoto Univ.]
Killing of HIV-1-infected CD4+ T cells and macrophages by an HIV-1 Nef-specific CD4+ CTL

P36
Keiko Sakai [Kumamoto Univ.]
HIV-1-induced homeostatic and developmental dysfunction of CD4+ T-cell subsets

P37
Hayato Murakoshi [Kumamoto Univ.]
Identification of HLA-B*4801-restricted HIV-1-Gag epitopes

P38 Hirokazu Koizumi [Kumamoto Univ.]
Different effects of HIV-1-specific CTLs having a strong ability to suppress HIV-1 replication on selection of escape mutant viruses

P39 Nozomi Kuse [Kumamoto Univ.]
Selection of HIV-1 escape mutants from HIV-1-specific CTLs in vitro HIV-1 replication assay

P40
Kazutaka Honda [Kumamoto Univ.]
Selection of escape mutant from HLA-Cw*1202-restricted cytotoxic T lymphocytes having a strong ability to suppress HIV-1 replication

 

←18 Sep.  
→19 Sep.